CTRI/2023/05/052604Not yet recruitingUnknown
Comparison of oral Terbinafine Vs oral Itraconazole in patients of Tinea Cruris in a tertiary care hospital of North East India- an open level randomized clinical trial
AGMC GBP Hospital0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •ALL NEWLY DIAGNOSED TINEA CRURIS SUBJECTS HAVE NOT RECEIVED ANTIFUNGAL IN LAST 14 DAYS
Exclusion Criteria
- •PREGNANT AND LACTATING WOMEN
- •PATIENTS ON IMMUNOSUPPRESSIVE DRUGS
- •PATIENTS UNWILLING FOR A REGULAR FOLLOW UP
- •PATIENTS WITH RELAPSE AND RECURRENT CASES OF TINEA CRURIS
Investigators
Similar Trials
Not yet recruiting
Phase 4
A randomized study to compare the safety and efficacy of terbinafine vs itraconazole in the treatment of recurrent tinea corporis and crurisCTRI/2023/07/055604Pt BD Sharma PGIMS Rohtak
Not yet recruiting
Not Applicable
oral terbinafine vs oral itraconazole in dermatophytic infectionsCTRI/2023/01/048940Rohilkhand Medical college and Hospitalr
Recruiting
Phase 2
The effect of terbinafine and itraconazole on the treatment of topical skin fungal infectioIRCT20090515001906N12Kermanshah University of Medical Sciences50
Recruiting
Phase 4
Treating dermatophytosis among childreDermatophytosisIRCT20230428058014N1PNS Shifa Hospital, Karachi200
Not yet recruiting
Phase 3
Treatment of ringworm (a fungal infection of skin) with combination of two oral antifungal drugs (terbinafine and griseofulvin)CTRI/2019/06/019778Institute of Medical Sciences